* required
Emerging Role of the Hepatic Thyroid Hormone Pathwayin the Pathophysiology of NASH
(as presented at EASL 2023)
with Prof Michael Trauner, Prof Jörn Schattenberg and Prof Meena Bansal, MD
NASH Patient Identification, Referral and Management in Endocrinology and Hepatology Practices
with Scott Isaacs, MD, FACE, FACP and Barton Isaac, PharmD
Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)
with Christina Hanson, MS, FNP and Ann Moore, FNP-C